CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease
Summary Caspase activation and recruitment domain 15 (CARD15) and Toll‐like receptor 4 (TLR4) are respectively intracellular and membrane‐bound receptors for bacterial cell wall components [respectively muramyl dipeptide (MDP) and lipopolysaccharide (LPS)]. Polymorphisms in CARD15 and TLR4 have been...
Saved in:
Published in | International Journal of Immunogenetics Vol. 34; no. 3; pp. 181 - 191 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.06.2007
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Summary
Caspase activation and recruitment domain 15 (CARD15) and Toll‐like receptor 4 (TLR4) are respectively intracellular and membrane‐bound receptors for bacterial cell wall components [respectively muramyl dipeptide (MDP) and lipopolysaccharide (LPS)]. Polymorphisms in CARD15 and TLR4 have been linked with Crohn's disease (CD). Adherent‐invasive Escherichia coli (AIEC) strains with particular adhesion and invasion characteristics have been specifically associated with CD ileal mucosa. The aim of this study was to investigate the functional impact of these polymorphisms on monocytes in patients with CD, in response to MDP, LPS and AIEC strain LF82. Monocytes were isolated from 40 patients with CD using magnetic cell sorting, stimulated with LPS or MDP or infected with AIEC. IL‐1β, IL‐6, IL‐8, IL‐10, IL‐12 and tumour necrosis factor alpha induction was assessed using quantitative real time–polymerase chain reaction, Cytometric Bead Array and ELISA. Bacterial intracellular survival and replication was assessed using a gentamicin protection assay. Results were linked with the presence of CARD15 and TLR4 polymorphisms. Monocytes of patients with CARD15 polymorphisms showed an early reduced cytokine response (IL‐1β, IL‐6 and IL‐10) to infection with AIEC, which was restored after 20 h. A gene–dose effect was seen, comparing wild‐types, heterozygotes and homozygotes. We found no differences in intracellular survival and replication of AIEC. Heterozygous carriage of TLR4 polymorphisms did not influence monocyte response. In conclusion, patients with CD carrying CARD15 polymorphisms show a disturbed early inflammatory monocyte response after infection with AIEC strain LF82. For the first time, a functional defect was detected in single heterozygous carriers. These findings reflect the potential role of a genetically altered host response to disease‐related bacteria in the pathogenesis of CD. |
---|---|
AbstractList | Summary
Caspase activation and recruitment domain 15 (CARD15) and Toll‐like receptor 4 (TLR4) are respectively intracellular and membrane‐bound receptors for bacterial cell wall components [respectively muramyl dipeptide (MDP) and lipopolysaccharide (LPS)]. Polymorphisms in
CARD15
and
TLR4
have been linked with Crohn's disease (CD). Adherent‐invasive
Escherichia coli
(AIEC) strains with particular adhesion and invasion characteristics have been specifically associated with CD ileal mucosa. The aim of this study was to investigate the functional impact of these polymorphisms on monocytes in patients with CD, in response to MDP, LPS and AIEC strain LF82. Monocytes were isolated from 40 patients with CD using magnetic cell sorting, stimulated with LPS or MDP or infected with AIEC. IL‐1β, IL‐6, IL‐8, IL‐10, IL‐12 and tumour necrosis factor alpha induction was assessed using quantitative real time–polymerase chain reaction, Cytometric Bead Array and ELISA. Bacterial intracellular survival and replication was assessed using a gentamicin protection assay. Results were linked with the presence of
CARD15
and
TLR4
polymorphisms. Monocytes of patients with
CARD15
polymorphisms showed an early reduced cytokine response (IL‐1β, IL‐6 and IL‐10) to infection with AIEC, which was restored after 20 h. A gene–dose effect was seen, comparing wild‐types, heterozygotes and homozygotes. We found no differences in intracellular survival and replication of AIEC. Heterozygous carriage of
TLR4
polymorphisms did not influence monocyte response. In conclusion, patients with CD carrying
CARD15
polymorphisms show a disturbed early inflammatory monocyte response after infection with AIEC strain LF82. For the first time, a functional defect was detected in single heterozygous carriers. These findings reflect the potential role of a genetically altered host response to disease‐related bacteria in the pathogenesis of CD. Caspase activation and recruitment domain 15 (CARD15) and Toll-like receptor 4 (TLR4) are respectively intracellular and membrane-bound receptors for bacterial cell wall components [respectively muramyl dipeptide (MDP) and lipopolysaccharide (LPS)]. Polymorphisms in CARD15 and TLR4 have been linked with Crohn's disease (CD). Adherent-invasive Escherichia coli (AIEC) strains with particular adhesion and invasion characteristics have been specifically associated with CD ileal mucosa. The aim of this study was to investigate the functional impact of these polymorphisms on monocytes in patients with CD, in response to MDP, LPS and AIEC strain LF82. Monocytes were isolated from 40 patients with CD using magnetic cell sorting, stimulated with LPS or MDP or infected with AIEC. IL-1beta, IL-6, IL-8, IL-10, IL-12 and tumour necrosis factor alpha induction was assessed using quantitative real time-polymerase chain reaction, Cytometric Bead Array and ELISA. Bacterial intracellular survival and replication was assessed using a gentamicin protection assay. Results were linked with the presence of CARD15 and TLR4 polymorphisms. Monocytes of patients with CARD15 polymorphisms showed an early reduced cytokine response (IL-1beta, IL-6 and IL-10) to infection with AIEC, which was restored after 20 h. A gene-dose effect was seen, comparing wild-types, heterozygotes and homozygotes. We found no differences in intracellular survival and replication of AIEC. Heterozygous carriage of TLR4 polymorphisms did not influence monocyte response. In conclusion, patients with CD carrying CARD15 polymorphisms show a disturbed early inflammatory monocyte response after infection with AIEC strain LF82. For the first time, a functional defect was detected in single heterozygous carriers. These findings reflect the potential role of a genetically altered host response to disease-related bacteria in the pathogenesis of CD. Caspase activation and recruitment domain 15 (CARD15) and Toll-like receptor 4 (TLR4) are respectively intracellular and membrane-bound receptors for bacterial cell wall components [respectively muramyl dipeptide (MDP) and lipopolysaccharide ( LPS)]. Polymorphisms in CARD15 and TLR4 have been linked with Crohn's disease (CD). Adherent-invasive Escherichia coli (AIEC) strains with particular adhesion and invasion characteristics have been specifically associated with CD ileal mucosa. The aim of this study was to investigate the functional impact of these polymorphisms on monocytes in patients with CD, in response to MDP, LPS and AIEC strain LF82. Monocytes were isolated from 40 patients with CD using magnetic cell sorting, stimulated with LPS or MDP or infected with AIEC. IL-1 beta, IL-6, IL-8, IL-10, IL-12 and tumour necrosis factor alpha induction was assessed using quantitative real time-polymerase chain reaction, Cytometric Bead Array and ELISA. Bacterial intracellular survival and replication was assessed using a gentamicin protection assay. Results were linked with the presence of CARD15 and TLR4 polymorphisms. Monocytes of patients with CARD15 polymorphisms showed an early reduced cytokine response (IL-1 beta, IL-6 and IL-10) to infection with AIEC, which was restored after 20 h. A gene-dose effect was seen, comparing wild-types, heterozygotes and homozygotes. We found no differences in intracellular survival and replication of AIEC. Heterozygous carriage of TLR4 polymorphisms did not influence monocyte response. In conclusion, patients with CD carrying CARD15 polymorphisms show a disturbed early inflammatory monocyte response after infection with AIEC strain LF82. For the first time, a functional defect was detected in single heterozygous carriers. These findings reflect the potential role of a genetically altered host response to disease-related bacteria in the pathogenesis of CD. Caspase activation and recruitment domain 15 (CARD15) and Toll-like receptor 4 (TLR4) are respectively intracellular and membrane-bound receptors for bacterial cell wall components [lsqb]respectively muramyl dipeptide (MDP) and lipopolysaccharide (LPS)[rsqb]. Polymorphisms in CARD15 and TLR4 have been linked with Crohn's disease (CD). Adherent-invasive Escherichia coli (AIEC) strains with particular adhesion and invasion characteristics have been specifically associated with CD ileal mucosa. The aim of this study was to investigate the functional impact of these polymorphisms on monocytes in patients with CD, in response to MDP, LPS and AIEC strain LF82. Monocytes were isolated from 40 patients with CD using magnetic cell sorting, stimulated with LPS or MDP or infected with AIEC. IL-1 beta , IL-6, IL-8, IL-10, IL-12 and tumour necrosis factor alpha induction was assessed using quantitative real time-polymerase chain reaction, Cytometric Bead Array and ELISA. Bacterial intracellular survival and replication was assessed using a gentamicin protection assay. Results were linked with the presence of CARD15 and TLR4 polymorphisms. Monocytes of patients with CARD15 polymorphisms showed an early reduced cytokine response (IL-1 beta , IL-6 and IL-10) to infection with AIEC, which was restored after 20 h. A gene-dose effect was seen, comparing wild-types, heterozygotes and homozygotes. We found no differences in intracellular survival and replication of AIEC. Heterozygous carriage of TLR4 polymorphisms did not influence monocyte response. In conclusion, patients with CD carrying CARD15 polymorphisms show a disturbed early inflammatory monocyte response after infection with AIEC strain LF82. For the first time, a functional defect was detected in single heterozygous carriers. These findings reflect the potential role of a genetically altered host response to disease-related bacteria in the pathogenesis of CD. Summary Caspase activation and recruitment domain 15 (CARD15) and Toll‐like receptor 4 (TLR4) are respectively intracellular and membrane‐bound receptors for bacterial cell wall components [respectively muramyl dipeptide (MDP) and lipopolysaccharide (LPS)]. Polymorphisms in CARD15 and TLR4 have been linked with Crohn's disease (CD). Adherent‐invasive Escherichia coli (AIEC) strains with particular adhesion and invasion characteristics have been specifically associated with CD ileal mucosa. The aim of this study was to investigate the functional impact of these polymorphisms on monocytes in patients with CD, in response to MDP, LPS and AIEC strain LF82. Monocytes were isolated from 40 patients with CD using magnetic cell sorting, stimulated with LPS or MDP or infected with AIEC. IL‐1β, IL‐6, IL‐8, IL‐10, IL‐12 and tumour necrosis factor alpha induction was assessed using quantitative real time–polymerase chain reaction, Cytometric Bead Array and ELISA. Bacterial intracellular survival and replication was assessed using a gentamicin protection assay. Results were linked with the presence of CARD15 and TLR4 polymorphisms. Monocytes of patients with CARD15 polymorphisms showed an early reduced cytokine response (IL‐1β, IL‐6 and IL‐10) to infection with AIEC, which was restored after 20 h. A gene–dose effect was seen, comparing wild‐types, heterozygotes and homozygotes. We found no differences in intracellular survival and replication of AIEC. Heterozygous carriage of TLR4 polymorphisms did not influence monocyte response. In conclusion, patients with CD carrying CARD15 polymorphisms show a disturbed early inflammatory monocyte response after infection with AIEC strain LF82. For the first time, a functional defect was detected in single heterozygous carriers. These findings reflect the potential role of a genetically altered host response to disease‐related bacteria in the pathogenesis of CD. |
Author | Rottiers, P. Bogaert, S. De Vos, M. Elewaut, D. Darfeuille-Michaud, A. Glasser, A.-L. De Keyser, Filip Peeters, H. Laukens, D. |
Author_xml | – sequence: 1 givenname: H. surname: Peeters fullname: Peeters, H. organization: Department of Gastroenterology, Ghent University Hospital, Ghent, Belgium – sequence: 2 givenname: S. surname: Bogaert fullname: Bogaert, S. organization: Department of Gastroenterology, Ghent University Hospital, Ghent, Belgium – sequence: 3 givenname: D. surname: Laukens fullname: Laukens, D. organization: Department of Molecular Biomedical Research, Ghent University and Flanders Interuniversity Institute for Biotechnology (VIB), Ghent, Belgium – sequence: 4 givenname: P. surname: Rottiers fullname: Rottiers, P. organization: Department of Molecular Biomedical Research, Ghent University and Flanders Interuniversity Institute for Biotechnology (VIB), Ghent, Belgium – sequence: 5 givenname: Filip surname: De Keyser fullname: De Keyser, Filip organization: Department of Rheumatology, Ghent University Hospital, Ghent, Belgium and – sequence: 6 givenname: A. surname: Darfeuille-Michaud fullname: Darfeuille-Michaud, A. organization: Laboratoire de Bactériologie, CBRV Université d'Auvergne, Clermont-Ferrand, France – sequence: 7 givenname: A.-L. surname: Glasser fullname: Glasser, A.-L. organization: Laboratoire de Bactériologie, CBRV Université d'Auvergne, Clermont-Ferrand, France – sequence: 8 givenname: D. surname: Elewaut fullname: Elewaut, D. organization: Department of Rheumatology, Ghent University Hospital, Ghent, Belgium and – sequence: 9 givenname: M. surname: De Vos fullname: De Vos, M. organization: Department of Gastroenterology, Ghent University Hospital, Ghent, Belgium |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17504508$$D View this record in MEDLINE/PubMed https://hal.inrae.fr/hal-02658036$$DView record in HAL |
BookMark | eNqNkc-O0zAQxiO0iP0Dr4B8AnFIsRPbSSQuVbvd7aoCCYHYmzV1JqpLYnfttLQvwHPjbKtyBF9mNP59M2N_18mFdRaThDA6YvF8XI9YwXmas_xxlFFajCiVBR3tXyRX54uLc56xy-Q6hDWlueScvkouWSEoF7S8Sn5Pxl-nTJAdeAO2D6TGHn1nLBIgtQn91i-xJgi-PRCPYeNsQOIa0jnr9KHHQHpHoF6hR9unxu4gmB2S26BjyeiVAaJda0joPRhLFrMyIzFOvFvZ92EYgRDwdfKygTbgm1O8Sb7Pbr9N7tPFl7v5ZLxINZcVTZmu8qWosgxqXVYgmCwESo2MFpKBXDKZZTSTTcO5bpZYNNAAZ_GhZVYzAJbfJB-OfVfQqo03HfiDcmDU_XihhlpUizL-025g3x3ZjXdPWwy96kzQ2LZg0W2DKqhgZcnEP0FWcVHl5QCWR1B7F4LH5rwCo2owVq3V4Jka_FODserZWLWP0renGdtlh_Vf4cnJCHw6Ar9Mi4f_bqzmD_OYRHl6lEfLcX-Wg_-pZJEXQv34fKc4l7PykU7VNP8DtEHB0w |
CitedBy_id | crossref_primary_10_1016_j_crohns_2008_02_003 crossref_primary_10_1016_j_ijmm_2014_01_002 crossref_primary_10_1097_QCO_0b013e32832a8a5d crossref_primary_10_4161_gmic_1_2_11142 crossref_primary_10_1002_ibd_21672 crossref_primary_10_1038_nrd2783 crossref_primary_10_4236_ojgas_2015_510024 crossref_primary_10_1002_ibd_21656 crossref_primary_10_1136_gutjnl_2017_314903 crossref_primary_10_1038_mi_2014_30 crossref_primary_10_1097_MIB_0000000000000946 crossref_primary_10_1371_journal_pone_0001359 crossref_primary_10_1002_ibd_21751 crossref_primary_10_2119_2007_00135_Ferwerda crossref_primary_10_1016_S1473_3099_08_70257_3 crossref_primary_10_1002_ibd_22908 crossref_primary_10_1007_s10620_017_4496_z crossref_primary_10_3389_fmed_2022_826240 crossref_primary_10_1097_MD_0000000000000051 crossref_primary_10_1186_1471_2180_9_180 crossref_primary_10_1097_MIB_0b013e3182802acc crossref_primary_10_1371_journal_pone_0007794 crossref_primary_10_7861_clinmedicine_11_1_8 crossref_primary_10_1097_MIB_0000000000000174 crossref_primary_10_1128_IAI_06230_11 crossref_primary_10_1159_000358143 |
Cites_doi | 10.1136/gut.2005.065888 10.1128/IAI.67.9.4499-4509.1999 10.1038/sj.gene.6364111 10.1074/jbc.M008072200 10.1074/jbc.C200651200 10.1136/gut.2003.032805 10.1084/jem.183.1.147 10.1038/41131 10.1053/j.gastro.2004.03.024 10.1053/gast.2003.50045 10.1016/S0016-5085(98)70476-7 10.1016/S0016-5085(98)70019-8 10.1093/hmg/ddh182 10.1038/35079107 10.1128/MCB.23.21.7531-7539.2003 10.1126/science.1103685 10.1111/j.1572-0241.2004.04040.x 10.3748/wjg.v11.i5.681 10.1086/378095 10.1053/gast.2003.50019 10.1128/IAI.69.4.2045-2053.2001 10.1038/ni1092 10.1007/s003840000227 10.1038/35079114 10.1074/jbc.M310556200 10.1016/j.bpg.2003.12.004 10.1053/gast.2003.50153 10.1084/jem.20030026 10.1146/annurev.immunol.21.120601.141126 10.1016/0140-6736(91)90663-A 10.1136/gut.2003.030205 10.1182/blood.V86.2.646.bloodjournal862646 10.1016/j.clim.2004.03.002 10.1038/76048 10.1093/clinchem/48.10.1661 10.1128/IAI.69.9.5529-5537.2001 10.1016/S0140-6736(05)66582-8 10.1084/jem.20022078 10.1053/bega.2002.0344 10.1002/eji.200425229 10.1053/j.gastro.2004.04.061 10.1111/j.1572-0241.2002.05613.x 10.1126/science.1104911 10.1074/jbc.C200673200 10.1016/0016-5085(95)90687-8 |
ContentType | Journal Article |
Copyright | Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: Distributed under a Creative Commons Attribution 4.0 International License |
DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7T5 8FD C1K FR3 H94 P64 RC3 7X8 1XC |
DOI | 10.1111/j.1744-313X.2007.00670.x |
DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Bacteriology Abstracts (Microbiology B) Immunology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic Hyper Article en Ligne (HAL) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Genetics Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic Genetics Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1744-313X 1365-2370 |
EndPage | 191 |
ExternalDocumentID | oai_HAL_hal_02658036v1 10_1111_j_1744_313X_2007_00670_x 17504508 IJI670 ark_67375_WNG_446F8X0D_D |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OB 1OC 29J 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB AOETA ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBC EBD EBS EBX EJD EMB EMK EMOBN EPT ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M KBYEO L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OBC OBS OIG OVD P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7T5 8FD C1K FR3 H94 P64 RC3 7X8 1XC |
ID | FETCH-LOGICAL-c4690-1c93b5922adc89a51675e6ce10761a6b1622026ff44cfbe7fafa4150882d1aa13 |
IEDL.DBID | DR2 |
ISSN | 1744-3121 |
IngestDate | Thu Oct 31 07:30:16 EDT 2024 Fri Aug 16 06:27:46 EDT 2024 Sat Aug 17 02:08:09 EDT 2024 Fri Aug 23 04:07:44 EDT 2024 Sat Sep 28 07:47:17 EDT 2024 Sat Aug 24 01:01:37 EDT 2024 Wed Oct 30 09:56:32 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | GENETIQUE PROTEINE CARD 15 IMMUNOLOGIE |
Language | English |
License | Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4690-1c93b5922adc89a51675e6ce10761a6b1622026ff44cfbe7fafa4150882d1aa13 |
Notes | ark:/67375/WNG-446F8X0D-D istex:46748E0F5A8E6B4050B76F2200D9965ECFCD9383 ArticleID:IJI670 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 17504508 |
PQID | 19459385 |
PQPubID | 23462 |
PageCount | 11 |
ParticipantIDs | hal_primary_oai_HAL_hal_02658036v1 proquest_miscellaneous_70518815 proquest_miscellaneous_19459385 crossref_primary_10_1111_j_1744_313X_2007_00670_x pubmed_primary_17504508 wiley_primary_10_1111_j_1744_313X_2007_00670_x_IJI670 istex_primary_ark_67375_WNG_446F8X0D_D |
PublicationCentury | 2000 |
PublicationDate | June 2007 |
PublicationDateYYYYMMDD | 2007-06-01 |
PublicationDate_xml | – month: 06 year: 2007 text: June 2007 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: England |
PublicationTitle | International Journal of Immunogenetics |
PublicationTitleAlternate | Int J Immunogenet |
PublicationYear | 2007 |
Publisher | Blackwell Publishing Ltd Wiley |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley |
References | Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A.L., Barnich, N., Bringer, M.A., Swidsinski, A., Beaugerie, L. & Colombel, J.F. (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology, 127, 412. Von Aulock, S., Schröder, N.W.J., Gueinzius, K., Traub, S., Hoffmann, S., Graf, K., Dimmeler, S., Hartung, T., Schumann, R.R. & Hermann, C. (2003) Heterozygous Toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. Journal of Infectious Diseases, 188, 938. Erridge, C., Stewart, J. & Poxton, I.R. (2003) Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. Journal of Experimental Medicine, 197, 1787. Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J.P., Belaiche, J. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 411, 599. Ogura, Y., Bonen, D.K., Inohara, N., Nicolae, D.L., Chen, F.F., Ramos, R. et al. (2001a) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 411, 603. Esters, N., Pierik, M., Van Steen, K., Vermeire, S., Claessens, G., Joossens, S., Vlietinck, R. & Rutgeerts, P. (2004) Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease. American Journal of Gastroenterology, 99, 316. Ma, X., Chow, J.M., Gri, G., Carra, G., Gerosa, F., Wolf, S.F., Dzialo, R. & Trinchieri, G. (1996) The interleukin 12 p40 gene promoter is primed by interferon-gamma in monocytic cells. Journal of Experimental Medicine, 183, 147. Medzithov, R., Preston-Hurlburt, P. & Janeway, C.A. Jr (1997) A human homologue of the Drosophyla Toll protein signals activation of adaptive immunity. Nature, 388, 394. Marteau, P., Seksik, P. & Shanahan, F. (2003) Manipulation of the bacterial flora in inflammatory bowel disease. Best Practice and Research. Clinical Gastroenterology, 17, 47. Liu, Y., Van Kruiningen, H.J., West, A.B., Cartun, R.W., Cortot, A. & Colombel, J.F. (1995) Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology, 108, 1396. Török, H.P., Glas, J., Tonenchi, L., Mussack, T. & Folwaczny, C. (2004) Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clinical Immunology, 112, 85. Wirtz, S. & Neurath, M.F. (2000) Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. International Journal of Colorectal Disease, 15, 144. Neut, C., Bulois, P., Desreumaux, P., Membre, J.M., Lederman, E., Gambiez, L., Cortot, A., Quandalle, P., Van Kruiningen, H. & Colombel, J.F. (2002) Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. American Journal of Gastroenterology, 97, 939. Philpott, D.J. & Viala, J. (2004) Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease. Best Practice and Research. Clinical Gastroenterology, 18, 555. Sartor, R.B. (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology, 126, 1620. Traub, S., Kubasch, N., Morath, S., Kresse, M., Hartung, T., Schmidt, R.R. & Hermann, C. (2004) Structural requirements of synthetic muropeptides to synergize with lipopolysaccharide in cytokine induction. Journal of Biological Chemistry, 279, 8694. Franchimont, D., Vermeire, S., El Housni, H., Pierik, M., Van Steen, K., Gustot, T. et al. (2004) Deficient host-bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 Asp299Gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut, 53, 987. Gazouli, M., Mantzaris, G., Kotsinas, A., Zacharatos, P., Papalambros, E., Archimandritis, A., Ikonomopoulos, J. & Gorgoulis, V.G. (2005) Association between polymorphisms in the Toll-like receptor 4, CD14 and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World Journal of Gastroenterology, 11, 681. Bonen, D.K., Ogura, Y., Nicolae, D.L., Inohara, N., Saab, L., Tanabe, T. et al. (2003b) Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology, 124, 140. D'Haens, G.R., Geboes, K., Peeters, M., Baert, F., Penninckx, F. & Rutgeerts, P. (1998) Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology, 114, 262. Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J. et al. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Journal of Biological Chemistry, 278, 5509. Schmitt, C., Humeny, A., Becker, C.M., Brune, K. & Pahl, A. (2002) Polymorphisms of TLR4: rapid genotyping and reduced response to lipopolysaccharide of TRL4 mutant alleles. Clinical Chemistry, 48, 1661. Glasser, A.L., Boudeau, J., Barnich, N., Perruchot, M.H., Colombel, J.F. & Darfeuille-Michaud, A. (2001) Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infection and Immunity, 69, 5529. Ogura, Y., Inohara, N., Benito, A., Chen, F.F., Yamaoka, S. & Nuñez, G. (2001b) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. Journal of Biological Chemistry, 276, 4812. Arbour, N.C., Lorenz, E., Schutte, B.C., Zabner, J., Kline, J.N., Jones, M., Frees, K., Watt, J.L. & Schwartz, D.A. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nature Genetics, 25, 187. Kobayashi, K.S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nuñez, G. & Flavell, R.A. (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science, 307, 731. Netea, M.G., Kullberg, B.J., De Jong, D.J., Franke, B., Sprong, T., Naber, T.H.J., Drenth, J.P.H. & Van der Meer, J.W.M. (2004) NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. European Journal of Immunology, 34, 2052. Takeda, K., Kaisho, T. & Akira, S. (2003) Toll-like receptors. Annual Review of Immunology, 21, 335. Van Heel, D.A., Ghosh, S., Butler, M., Hunt, K., Lundberg, A.M.C., Ahmad, T. et al. (2005a) Muramyl dipeptide and Toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet, 365, 1794. Yang, S., Tamai, R., Akashi, S., Takeuchi, O., Akira, S., Sugawara, S. & Takada, H. (2001) Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infection and Immunity, 69, 2045. Boudeau, J., Glasser, A.L., Masseret, E., Joly, B. & Darfeuille-Michaud, A. (1999) Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patients with Crohn's disease. Infection and Immunity, 67, 4499. Hayes, M.P., Wang, J. & Norcross, M.A. (1995) Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-γ of lipopolysaccharide-inducible p35 and p40 genes. Blood, 86, 646. Rutgeerts, P., Geboes, K., Peeters, M., Hiele, M., Penninckx, F., Aerts, R., Kerremans, R. & Vantrappen, G. (1991) Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet, 338, 771. Darfeuille-Michaud, A., Neut, C., Barnich, N., Lederman, E., Di Martino, P., Desreumaux, P., Gambiez, L., Joly, B., Cortot, A. & Colombel, J.F. (1998) Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology, 115, 1405. Watanabe, T., Kitani, A., Murray, P.J. & Strober, W. (2004) NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nature Immunology, 5, 800. Liu, J., Cao, S., Herman, L.M. & Ma, X. (2003) Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1. Journal of Experimental Medicine, 198, 1265. Hisamatsu, T., Suzuki, M., Reinecker, H.C., Nadeau, W.J., McCormick, B.A. & Podolsky, D.K. (2003) CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology, 124, 993. Maeda, S., Hsu, L.C., Liu, H., Bankston, L.A., Iimura, M., Kagnoff, M.F., Eckmann, L. & Karin, M. (2005) NOD2 mutation in Crohn's disease potentiates NF-kB activity and IL-1β processing. Science, 307, 734. Wehkamp, J., Harder, J., Weichenthal, M., Schwab, M., Schaffeler, E., Schlee, M. et al. (2004) NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut, 53, 1658. Pauleau, A.L. & Murray, P.J. (2003) Role of NOD2 in the response of macrophages to Toll-like receptor agonists. Molecular and Cellular Biology, 23, 7531. Van Heel, D.A., Ghosh, S., Hunt, K., Mathew, C., Forbes, A., Jewell, D. & Playford, R. (2005b) Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. Gut, 54, 1553. Girardin, S.E., Boneca, I.G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D.J. & Sansonetti, P.J. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. Journal of Biological Chemistry, 278, 8869. Bonen, D.K. & Cho, J.H. (2003a) The genetics of inflammatory bowel disease. Gastroenterology, 124, 521. Li, J., Moran, T., Swanson, E., Julian, C., Harris, J., Bonen, D.K., Hedl, M., Nicolae, D.L., Abraham, C. & Cho, J.H. (2004) Regulation of IL-8 and IL-1β expression in Crohn's disease associated NOD2/CARD15 mutations. Human Molecular Genetics, 13, 1715. Arnott, I.D., Nimmo, E.R., Drummond, H.E., Fennell, J., Smith, B.R., MacKinlay, E. et al. (2004) NO 2004; 127 2004; 126 2000; 25 2002; 97 2001b; 276 1999; 67 1996; 183 2005b; 54 2004; 5 1998; 115 2003; 17 1998; 114 1991; 338 2003a; 124 2003; 278 2001; 69 2003; 198 2003; 197 1995; 86 1997; 388 2001a; 411 2004; 112 2003b; 124 2004; 99 2004; 53 2002; 48 2004; 279 2004; 18 2000; 15 2005a; 365 1995; 108 2004; 34 2004; 13 2005; 307 2003; 124 2003; 188 2005; 11 2001; 411 2003; 21 2003; 23 Schmitt C. (e_1_2_14_37_1) 2002; 48 e_1_2_14_30_1 e_1_2_14_31_1 e_1_2_14_11_1 e_1_2_14_34_1 e_1_2_14_10_1 e_1_2_14_35_1 e_1_2_14_13_1 e_1_2_14_32_1 e_1_2_14_12_1 e_1_2_14_33_1 e_1_2_14_15_1 e_1_2_14_38_1 e_1_2_14_14_1 e_1_2_14_39_1 e_1_2_14_17_1 e_1_2_14_36_1 e_1_2_14_16_1 e_1_2_14_29_1 e_1_2_14_6_1 e_1_2_14_5_1 e_1_2_14_8_1 Boudeau J. (e_1_2_14_7_1) 1999; 67 e_1_2_14_9_1 e_1_2_14_2_1 e_1_2_14_41_1 e_1_2_14_20_1 e_1_2_14_42_1 e_1_2_14_4_1 e_1_2_14_3_1 e_1_2_14_40_1 e_1_2_14_23_1 e_1_2_14_45_1 e_1_2_14_24_1 e_1_2_14_46_1 e_1_2_14_21_1 e_1_2_14_43_1 e_1_2_14_22_1 e_1_2_14_44_1 e_1_2_14_27_1 e_1_2_14_28_1 e_1_2_14_25_1 e_1_2_14_26_1 e_1_2_14_19_1 e_1_2_14_18_1 |
References_xml | – volume: 388 start-page: 394 year: 1997 article-title: A human homologue of the Toll protein signals activation of adaptive immunity publication-title: Nature – volume: 124 start-page: 993 year: 2003 article-title: CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells publication-title: Gastroenterology – volume: 115 start-page: 1405 year: 1998 article-title: Presence of adherent strains in ileal mucosa of patients with Crohn's disease publication-title: Gastroenterology – volume: 97 start-page: 939 year: 2002 article-title: Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease publication-title: American Journal of Gastroenterology – volume: 11 start-page: 681 year: 2005 article-title: Association between polymorphisms in the Toll‐like receptor 4, CD14 and CARD15/NOD2 and inflammatory bowel disease in the Greek population publication-title: World Journal of Gastroenterology – volume: 411 start-page: 599 year: 2001 article-title: Association of NOD2 leucine‐rich repeat variants with susceptibility to Crohn's disease publication-title: Nature – volume: 183 start-page: 147 year: 1996 article-title: The interleukin 12 p40 gene promoter is primed by interferon‐gamma in monocytic cells publication-title: Journal of Experimental Medicine – volume: 197 start-page: 1787 year: 2003 article-title: Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll‐like receptor 4 gene show no deficit in lipopolysaccharide signalling publication-title: Journal of Experimental Medicine – volume: 278 start-page: 8869 year: 2003 article-title: Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection publication-title: Journal of Biological Chemistry – volume: 365 start-page: 1794 year: 2005a article-title: Muramyl dipeptide and Toll‐like receptor sensitivity in NOD2‐associated Crohn's disease publication-title: Lancet – volume: 53 start-page: 987 year: 2004 article-title: Deficient host–bacteria interactions in inflammatory bowel disease? The Toll‐like receptor (TLR)‐4 Asp299Gly polymorphism is associated with Crohn's disease and ulcerative colitis publication-title: Gut – volume: 188 start-page: 938 year: 2003 article-title: Heterozygous Toll‐like receptor 4 polymorphism does not influence lipopolysaccharide‐induced cytokine release in human whole blood publication-title: Journal of Infectious Diseases – volume: 124 start-page: 140 year: 2003b article-title: Crohn's disease‐associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan publication-title: Gastroenterology – volume: 411 start-page: 603 year: 2001a article-title: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease publication-title: Nature – volume: 69 start-page: 2045 year: 2001 article-title: Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture publication-title: Infection and Immunity – volume: 18 start-page: 555 year: 2004 article-title: Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease publication-title: Best Practice and Research. Clinical Gastroenterology – volume: 5 start-page: 800 year: 2004 article-title: NOD2 is a negative regulator of Toll‐like receptor 2‐mediated T helper type 1 responses publication-title: Nature Immunology – volume: 112 start-page: 85 year: 2004 article-title: Polymorphisms of the lipopolysaccharide‐signaling complex in inflammatory bowel disease: association of a mutation in the Toll‐like receptor 4 gene with ulcerative colitis publication-title: Clinical Immunology – volume: 276 start-page: 4812 year: 2001b article-title: Nod2, a Nod1/Apaf‐1 family member that is restricted to monocytes and activates NF‐κB publication-title: Journal of Biological Chemistry – volume: 67 start-page: 4499 year: 1999 article-title: Invasive ability of an strain isolated from the ileal mucosa of a patients with Crohn's disease publication-title: Infection and Immunity – volume: 15 start-page: 144 year: 2000 article-title: Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease publication-title: International Journal of Colorectal Disease – volume: 307 start-page: 731 year: 2005 article-title: Nod2‐dependent regulation of innate and adaptive immunity in the intestinal tract publication-title: Science – volume: 108 start-page: 1396 year: 1995 article-title: Immunocytochemical evidence of , , and antigens in Crohn's disease publication-title: Gastroenterology – volume: 338 start-page: 771 year: 1991 article-title: Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum publication-title: Lancet – volume: 25 start-page: 187 year: 2000 article-title: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans publication-title: Nature Genetics – volume: 307 start-page: 734 year: 2005 article-title: NOD2 mutation in Crohn's disease potentiates NF‐kB activity and IL‐1β processing publication-title: Science – volume: 21 start-page: 335 year: 2003 article-title: Toll‐like receptors publication-title: Annual Review of Immunology – volume: 5 start-page: 417 year: 2004 article-title: NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? publication-title: Genes and Immunity – volume: 23 start-page: 7531 year: 2003 article-title: Role of NOD2 in the response of macrophages to Toll‐like receptor agonists publication-title: Molecular and Cellular Biology – volume: 48 start-page: 1661 year: 2002 article-title: Polymorphisms of TLR4: rapid genotyping and reduced response to lipopolysaccharide of TRL4 mutant alleles publication-title: Clinical Chemistry – volume: 53 start-page: 1658 year: 2004 article-title: NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha‐defensin expression publication-title: Gut – volume: 34 start-page: 2052 year: 2004 article-title: NOD2 mediates anti‐inflammatory signals induced by TLR2 ligands: implications for Crohn's disease publication-title: European Journal of Immunology – volume: 278 start-page: 5509 year: 2003 article-title: Host recognition of bacterial muramyl dipeptide mediated through NOD2 publication-title: Journal of Biological Chemistry – volume: 124 start-page: 521 year: 2003a article-title: The genetics of inflammatory bowel disease publication-title: Gastroenterology – volume: 54 start-page: 1553 year: 2005b article-title: Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease publication-title: Gut – volume: 114 start-page: 262 year: 1998 article-title: Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum publication-title: Gastroenterology – volume: 126 start-page: 1620 year: 2004 article-title: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics publication-title: Gastroenterology – volume: 279 start-page: 8694 year: 2004 article-title: Structural requirements of synthetic muropeptides to synergize with lipopolysaccharide in cytokine induction publication-title: Journal of Biological Chemistry – volume: 86 start-page: 646 year: 1995 article-title: Regulation of interleukin‐12 expression in human monocytes: selective priming by interferon‐γ of lipopolysaccharide‐inducible p35 and p40 genes publication-title: Blood – volume: 17 start-page: 47 year: 2003 article-title: Manipulation of the bacterial flora in inflammatory bowel disease publication-title: Best Practice and Research. Clinical Gastroenterology – volume: 198 start-page: 1265 year: 2003 article-title: Differential regulation of interleukin (IL)‐12 p35 and p40 gene expression and interferon (IFN)‐gamma‐primed IL‐12 production by IFN regulatory factor 1 publication-title: Journal of Experimental Medicine – volume: 99 start-page: 316 year: 2004 article-title: Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease publication-title: American Journal of Gastroenterology – volume: 127 start-page: 412 year: 2004 article-title: High prevalence of adherent‐invasive associated with ileal mucosa in Crohn's disease publication-title: Gastroenterology – volume: 69 start-page: 5529 year: 2001 article-title: Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death publication-title: Infection and Immunity – volume: 13 start-page: 1715 year: 2004 article-title: Regulation of IL‐8 and IL‐1β expression in Crohn's disease associated NOD2/CARD15 mutations publication-title: Human Molecular Genetics – ident: e_1_2_14_42_1 doi: 10.1136/gut.2005.065888 – volume: 67 start-page: 4499 year: 1999 ident: e_1_2_14_7_1 article-title: Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patients with Crohn's disease publication-title: Infection and Immunity doi: 10.1128/IAI.67.9.4499-4509.1999 contributor: fullname: Boudeau J. – ident: e_1_2_14_3_1 doi: 10.1038/sj.gene.6364111 – ident: e_1_2_14_32_1 doi: 10.1074/jbc.M008072200 – ident: e_1_2_14_15_1 doi: 10.1074/jbc.C200651200 – ident: e_1_2_14_44_1 doi: 10.1136/gut.2003.032805 – ident: e_1_2_14_25_1 doi: 10.1084/jem.183.1.147 – ident: e_1_2_14_28_1 doi: 10.1038/41131 – ident: e_1_2_14_36_1 doi: 10.1053/j.gastro.2004.03.024 – ident: e_1_2_14_5_1 doi: 10.1053/gast.2003.50045 – ident: e_1_2_14_8_1 doi: 10.1016/S0016-5085(98)70476-7 – ident: e_1_2_14_10_1 doi: 10.1016/S0016-5085(98)70019-8 – ident: e_1_2_14_22_1 doi: 10.1093/hmg/ddh182 – ident: e_1_2_14_19_1 doi: 10.1038/35079107 – ident: e_1_2_14_33_1 doi: 10.1128/MCB.23.21.7531-7539.2003 – ident: e_1_2_14_26_1 doi: 10.1126/science.1103685 – ident: e_1_2_14_12_1 doi: 10.1111/j.1572-0241.2004.04040.x – ident: e_1_2_14_14_1 doi: 10.3748/wjg.v11.i5.681 – ident: e_1_2_14_4_1 doi: 10.1086/378095 – ident: e_1_2_14_6_1 doi: 10.1053/gast.2003.50019 – ident: e_1_2_14_46_1 doi: 10.1128/IAI.69.4.2045-2053.2001 – ident: e_1_2_14_43_1 doi: 10.1038/ni1092 – ident: e_1_2_14_45_1 doi: 10.1007/s003840000227 – ident: e_1_2_14_31_1 doi: 10.1038/35079114 – ident: e_1_2_14_40_1 doi: 10.1074/jbc.M310556200 – ident: e_1_2_14_34_1 doi: 10.1016/j.bpg.2003.12.004 – ident: e_1_2_14_18_1 doi: 10.1053/gast.2003.50153 – ident: e_1_2_14_23_1 doi: 10.1084/jem.20030026 – ident: e_1_2_14_38_1 doi: 10.1146/annurev.immunol.21.120601.141126 – ident: e_1_2_14_35_1 doi: 10.1016/0140-6736(91)90663-A – ident: e_1_2_14_13_1 doi: 10.1136/gut.2003.030205 – ident: e_1_2_14_17_1 doi: 10.1182/blood.V86.2.646.bloodjournal862646 – ident: e_1_2_14_39_1 doi: 10.1016/j.clim.2004.03.002 – ident: e_1_2_14_2_1 doi: 10.1038/76048 – volume: 48 start-page: 1661 year: 2002 ident: e_1_2_14_37_1 article-title: Polymorphisms of TLR4: rapid genotyping and reduced response to lipopolysaccharide of TRL4 mutant alleles publication-title: Clinical Chemistry doi: 10.1093/clinchem/48.10.1661 contributor: fullname: Schmitt C. – ident: e_1_2_14_16_1 doi: 10.1128/IAI.69.9.5529-5537.2001 – ident: e_1_2_14_41_1 doi: 10.1016/S0140-6736(05)66582-8 – ident: e_1_2_14_11_1 doi: 10.1084/jem.20022078 – ident: e_1_2_14_27_1 doi: 10.1053/bega.2002.0344 – ident: e_1_2_14_29_1 doi: 10.1002/eji.200425229 – ident: e_1_2_14_9_1 doi: 10.1053/j.gastro.2004.04.061 – ident: e_1_2_14_30_1 doi: 10.1111/j.1572-0241.2002.05613.x – ident: e_1_2_14_21_1 doi: 10.1126/science.1104911 – ident: e_1_2_14_20_1 doi: 10.1074/jbc.C200673200 – ident: e_1_2_14_24_1 doi: 10.1016/0016-5085(95)90687-8 |
SSID | ssj0036440 ssj0013196 |
Score | 1.9569075 |
Snippet | Summary
Caspase activation and recruitment domain 15 (CARD15) and Toll‐like receptor 4 (TLR4) are respectively intracellular and membrane‐bound receptors for... Caspase activation and recruitment domain 15 (CARD15) and Toll-like receptor 4 (TLR4) are respectively intracellular and membrane-bound receptors for bacterial... |
SourceID | hal proquest crossref pubmed wiley istex |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 181 |
SubjectTerms | Acetylmuramyl-Alanyl-Isoglutamine - pharmacology Adjuvants, Immunologic - pharmacology Adult Aged Crohn Disease - genetics Crohn Disease - immunology Cytokines - genetics Cytokines - immunology Escherichia coli Escherichia coli - growth & development Escherichia coli - immunology Escherichia coli - pathogenicity Escherichia coli Infections - immunology Escherichia coli Infections - microbiology Female Humans Life Sciences Lipopolysaccharides - pharmacology Male Middle Aged Monocytes - drug effects Monocytes - immunology Monocytes - microbiology Nod2 Signaling Adaptor Protein - genetics Nod2 Signaling Adaptor Protein - immunology Polymorphism, Genetic RNA, Messenger - metabolism Toll-Like Receptor 4 - genetics |
Title | CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease |
URI | https://api.istex.fr/ark:/67375/WNG-446F8X0D-D/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1744-313X.2007.00670.x https://www.ncbi.nlm.nih.gov/pubmed/17504508 https://search.proquest.com/docview/19459385 https://search.proquest.com/docview/70518815 https://hal.inrae.fr/hal-02658036 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9swEBbtlkIvfT-8fYlS2pNDZD1sH0OyaXbZ7mHp0tyELMskBOxiO2F3Tz322N_YX9IZP9Jm2UIpPdkY2XjG30gz1qdPhLyFHk9YEypfysD6IlXSN9waP0iVsUI6KKFxRvfjiZqdiaO5nHf8J1wL0-pDbH-4YWQ0_TUGuEmq3SAPhYA-hM97JUIVDgeYTzIeIrtrcrpVkuIw7HdrI_GWgF0l9VzzoJ2R6uYCeZK30PXn1yWju7ltMzhN75FVb1bLSVkN1nUysJdXFB__j933yd0uh6WjFnQPyA2XPyS3210tLx6Rb-PR6YRJuoEyHFk2NO0oN44amoJt6zJxKXUorUzLlqPraJFRiIjCXkDuS-uCmnSBKxHrH1-_L_ONQZY9PagQYkukZ1MA8JJWzQ4X9HgaBRSO47JY5O8r2s06PSZn04NP45nfbfjgW6zSfWZjnsg4CExqo9hIBtWMU9Yx_NliVMJUEEDNmGWAryxxYWYyI1DQPgpSZgzjT8heXuTuGaHOci6TWHIZpkKZMEYdHCkUlLPKWmk8wvqPq7-0uh76t3oIPKzRw7hLJ07Qg4f1uUfeAAq2zVGYezY61ngN3kpGgLIN88i7BiTbZqZcIXkulPrzyQcN1fc0mg8neuKR1z2KNIQ0ztOY3BXrSjN405hH8s8twiHq6DFo8bSF3y8bUK4fPOIR2YDor43Th0eHcLL_j_c9J3d6JuWQvSB7dbl2LyFdq5NXTSD-BCJaL7o |
link.rule.ids | 230,315,783,787,888,1378,27936,27937,46306,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9MwFLdgE4LL-BwLX7MQglOqOo6d5Fi1K-3oepg20ZvlOI5aDSUoTauNE0eO_I38JbyXj0KnISHEqVHlRHnO79nv2T__HiFvYMTzjQ6kK4RnXD-RwtXcaNdLpDa-sJBC447uyVSOzv3jmZg15YDwLEytD7FZcEPPqMZrdHBckN728sD3YRDhs1aKUAbdDgSUu-D9HOs4DE43WlIcJv7mdCTe47HrtJ4bnrQ1V92eI1NyFzv_8qZwdDu6raan4X3yqTWsZqVcdFZl3DFfrmk-_ifLH5C9JoylvRp3D8ktmz0id-rCllePybd-73TABF1DJo5EG5o0rBtLNU3AuFUR24RaVFemRU3TtTRPKThFbq4g_KVlTnUyx8OI5Y-v3xfZWiPRnh4tEWULZGhTwPCCLqsiF3QyDD0Kv_0in2fvlrTZeHpCzodHZ_2R29R8cA0m6i4zEY9F5Hk6MWGkBYOExkpjGa63aBkz6XmQNqYpQCyNbZDqVPuoaR96CdOa8X2yk-WZPSDUGs5FHAkugsSXOohQCkf4EjJaaYzQDmHt11Wfa2kP9VtKBD2ssIexUCfu0UMPq0uHvAYYbJqjNveoN1H4H7yVCAFma-aQtxVKNs10cYH8uUCoj9P3ChLwYTjrDtTAIYctjBR4NW7V6Mzmq6Vi8KYRD8WfWwRdlNJj0OJpjb9fNqBiP_SIQ0SFor82To2Px3Dx7B_vOyR3R2cnEzUZTz88J_daYmWXvSA7ZbGyLyF6K-NXlVf-BA9sM9I |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZgVyAuyxvCay2E4JSqTmInOVbthnYpFVqxojfLsR21qpSs2rTa3RNHjvxGfgkzeRS6WiSEOCWKnCgz-caeiT9_JuQN9HiBVqFwOfe0GxjBXeVr5XpGKB1wCyU0zuh-nIjhaXA85dOG_4RrYWp9iO0PN4yMqr_GAD8z2W6Qh0EAfYg_bZUIRdjtQD65HwhIhDFBOtlKSfkw7jeLI_Eej11l9VzzpJ2h6uYMiZL76Pvz67LR3eS2Gp2Su2TR2lWTUhaddZl29OUVycf_Y_g9ctAksbRXo-4-uWHzB-RWva3lxUPyrd87GTBON1CHI82GmoZzY6miBmxbL1NrqEVtZbqsSbqWFhmFkCj0BSS_tCyoMjNcilj--Pp9nm8U0uzp0QoxNkd-NgUEz-mq2uKCjpPIo3DsL4tZ_m5Fm2mnR-Q0OfrcH7rNjg-uxjLdZTr2Ux57njI6ihVnUM5YoS3Dvy1KpEx4HhSNWQYAy1IbZipTASraR55hSjH_MdnLi9w-JdRq3-dpzH0emkCoMEYhHB4IqGeF1lw5hLUfV57Vwh7yt4IIPCzRw7hNJ87Qg4fluUNeAwq2zVGZe9gbS7wGb8UjQNmGOeRtBZJtM7VcIHsu5PLL5L2E8juJpt2BHDjksEWRhJjGiRqV22K9kgzeNPYj_ucWYReF9Bi0eFLD75cNqNcPHnEIr0D018bJ0fEITp79432H5PanQSLHo8mH5-ROy6rsshdkr1yu7UtI3cr0VRWTPwE3uDKB |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CARD15+variants+determine+a+disturbed+early+response+of+monocytes+to+adherent%E2%80%90invasive+Escherichia+coli+strain+LF82+in+Crohn%27s+disease&rft.jtitle=International+journal+of+immunogenetics&rft.au=Peeters%2C+H.&rft.au=Bogaert%2C+S.&rft.au=Laukens%2C+D.&rft.au=Rottiers%2C+P.&rft.date=2007-06-01&rft.issn=1744-3121&rft.eissn=1744-313X&rft.volume=34&rft.issue=3&rft.spage=181&rft.epage=191&rft_id=info:doi/10.1111%2Fj.1744-313X.2007.00670.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1744_313X_2007_00670_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1744-3121&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1744-3121&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1744-3121&client=summon |